A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

UC Davis Comprehensive Cancer Center is testing a drug called niraparib (ZEJULA), given before prostate cancer surgery.

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Social media can push vulnerable young people toward developing eating disorders by glorifying thinness and promoting fake, ...

Stress from work doesn't always stay at the office—and it may be affecting more than just your mood. A new study finds that ...

Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are among the most well-known ...